← All trials
NCT06313697
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 23, 2024
- Primary completion
- Jan 6, 2025
- Completion date
- Dec 6, 2025
- First posted
- Mar 15, 2024
- Last posted
- Aug 22, 2024
- Enrollment
- 132
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of ChinaLead sponsor
- Shandong first medical UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.